Vivani Medical grants CFO options and RSUs
Vivani Medical, Inc. reported that its Chief Financial Officer Anthony Baldor received equity awards consisting of stock options for 75,000 shares at an exercise price of $1.31 per share and 37,500 performance-based RSUs.
Rhea-AI Filing Summary
Vivani Medical, Inc. reported that its Chief Financial Officer Anthony Baldor received equity awards consisting of stock options for 75,000 shares at an exercise price of $1.31 per share and 37,500 performance-based RSUs. The options vest 25% after one year then monthly over 36 months and expire in 2036, while the RSUs vest in three stages only if the stock trades at or above $3.15 for three consecutive trading days within four years.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 112,500 shares
Grant/Award
2 txns
Insider
Baldor Anthony
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock Option F1 | 75,000 | $0.00 | $0.00 |
| Grant/Award | RSUs F2, F3 | 37,500 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock Option — 75,000 contracts (Direct);
RSUs — 37,500 contracts (Direct)
Footnotes (3)
- F1. The stock options have a 10-year term and vest 25% at one-year and monthly thereafter for 36 months, subject to the Reporting Person's continued service through each applicable vesting date.
- F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Vivani common stock.
- F3. The performance based RSUs shall vest in three stages: one-third when the stock price is at or above $3.15 for three consecutive trading days, another one-third one year after this date when the market condition is first achieved, and the final one-third one year after this second vesting date when the market condition is achieved, subject to the Reporting Person's continued service through each applicable vesting date. If the RSUs fail to be at or above $3.15 for three consecutive trading dates within a four year term from the date of the grant, the RSUs shall expire.
Key Figures
Stock options granted: 75,000 options
Exercise price: $1.31 per share
Option expiration: 2036-07-27
+3 more
6 metrics
Stock options granted
75,000 options
Grant to CFO Anthony Baldor on 2026-07-28
Exercise price
$1.31 per share
Exercise price of CFO stock option grant
Option expiration
2036-07-27
10-year term for the 75,000 stock options
RSUs granted
37,500 RSUs
Performance-based RSUs granted to CFO on 2026-07-28
RSU share-price hurdle
$3.15
Stock price required for RSUs to begin vesting
RSU performance window
4 years
Period during which $3.15 condition must be met
Key Terms
restricted stock unit, performance based RSUs, exercise price, market condition
4 terms
restricted stock unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
performance based RSUs financial
"The performance based RSUs shall vest in three stages"
exercise price financial
"conversion or exercise price: 1.3100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
market condition financial
"when the market condition is first achieved"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Vivani Medical (VANI) report for its CFO?
Vivani Medical reported that CFO Anthony Baldor received a grant of 75,000 stock options and 37,500 performance-based RSUs as equity compensation on July 28, 2026, increasing his potential future ownership in the company.
What are the key terms of Anthony Baldor’s 75,000 Vivani (VANI) stock options?
The grant covers 75,000 options with an exercise price of $1.31 per share. They have a 10-year term expiring on 2036-07-27 and vest 25% after one year, then monthly over the following 36 months, contingent on continued service.
How many RSUs did Vivani Medical (VANI) grant to its CFO and what do they represent?
Vivani granted 37,500 RSUs to its CFO. Each restricted stock unit represents a contingent right to receive one share of Vivani common stock, subject to meeting specified stock price performance conditions and continued service through each vesting date.
What stock price condition must Vivani (VANI) meet for the CFO’s RSUs to start vesting?
The performance-based RSUs begin vesting only if Vivani’s stock trades at or above $3.15 for three consecutive trading days. This market condition must be achieved within a four-year term from the grant date for any RSUs to vest.
How do the performance-based RSUs for Vivani (VANI) CFO vest over time?
The RSUs vest in three stages: one-third when the $3.15 hurdle is first met, another one-third one year later, and the final one-third one year after that, each subject to continued service and the stock price condition being achieved.
What happens if Vivani (VANI) stock never reaches the $3.15 target for the CFO’s RSUs?
If the stock does not reach or exceed $3.15 for three consecutive trading days within four years from the grant date, the performance-based RSUs will expire, and no shares will be delivered under that award.
Were Vivani (VANI) CFO’s equity awards reported under a Rule 10b5-1 trading plan?
The filing shows the Rule 10b5-1 checkbox as not checked, indicating these equity awards were not reported as granted pursuant to a Rule 10b5-1 trading plan, but rather as standard compensation grants.
AI-generated analysis. How Rhea-AI works. Not financial advice.
